This week's FierceBiotech is brought to you by CMIC. Trouble viewing? Click here.
*|MC_PREVIEW_TEXT|*
[WEBINAR] Orphan Drug Development in Japan How can we accelerate rare disease patients' access to therapies?
March 10th: 11AM-12PM (EDT)/3PM-4PM (GMT)Overview of current rare disease market in JapanHighlight of recent regulatory process & requirementsSupport for Orphan drugs development in JapanRare disease patients in Japan
Your Trusted Service Partner for Asia Clinical Trials
CMIC is the largest CRO in Japan, involved in near 80% of Japan’s new drug development and filingBroad coverage in APAC region, supporting clinical trials in 13 countriesUnique business model (PVC) to provide end-to-end solutionsLocal regulatory expertise and strong network with local opinion leaders
Connect with Us We want to connect with you and discuss your current projects, needs and answer any questions you may have, no matter where you are in the drug development process.
Want to reach 137,000+ FierceBiotech subscribers with your own message? Contact [email protected] or call 202-824-5074.
